ECLECOLAB INC.

NYSE ecolab.com


$ 236.69 $ -2.74 (-1.15 %)    

Friday, 02-Aug-2024 15:44:39 EDT
QQQ $ 447.87 $ -3.97 (-0.88 %)
DIA $ 396.04 $ -2.71 (-0.68 %)
SPY $ 531.82 $ -5.47 (-1.02 %)
TLT $ 98.29 $ 0.66 (0.68 %)
GLD $ 225.30 $ -2.71 (-1.19 %)
$ 240.24
$ 239.43
$ 236.63 x 100
$ 236.75 x 101
$ 234.50 - $ 240.96
$ 155.51 - $ 249.00
1,902,639
na
68.36B
$ 1.23
$ 39.92
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-02-2024 06-30-2024 10-Q
2 05-02-2024 03-31-2024 10-Q
3 02-23-2024 12-31-2023 10-K
4 11-02-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 05-04-2023 03-31-2023 10-Q
7 02-24-2023 12-31-2022 10-K
8 11-04-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 05-05-2022 03-31-2022 10-Q
11 02-25-2022 12-31-2021 10-K
12 10-29-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 05-06-2021 03-31-2021 10-Q
15 02-26-2021 12-31-2020 10-K
16 10-30-2020 09-30-2020 10-Q
17 08-06-2020 06-30-2020 10-Q
18 05-07-2020 03-31-2020 10-Q
19 02-28-2020 12-31-2019 10-K
20 10-31-2019 09-30-2019 10-Q
21 08-01-2019 06-30-2019 10-Q
22 05-02-2019 03-31-2019 10-Q
23 03-01-2019 12-31-2018 10-K
24 11-01-2018 09-30-2018 10-Q
25 08-02-2018 06-30-2018 10-Q
26 05-03-2018 03-31-2018 10-Q
27 02-23-2018 12-31-2017 10-K
28 11-02-2017 09-30-2017 10-Q
29 08-03-2017 06-30-2017 10-Q
30 05-04-2017 03-31-2017 10-Q
31 02-24-2017 12-31-2016 10-K
32 11-03-2016 09-30-2016 10-Q
33 08-04-2016 06-30-2016 10-Q
34 05-05-2016 03-31-2016 10-Q
35 02-26-2016 12-31-2015 10-K
36 11-02-2015 09-30-2015 10-Q
37 08-06-2015 06-30-2015 10-Q
38 05-07-2015 03-31-2015 10-Q
39 02-27-2015 12-31-2014 10-K
40 10-30-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ecolab-closes-sale-of-global-surgical-solutions-business-for-950m-in-cash-announces-intent-to-repurchase-up-to-500m-of-its-stock

Announces Intent to Repurchase up to $500 Million of Its StockEcolab Inc. today closed on the sale of its global surgical solut...

 jp-morgan-maintains-neutral-on-ecolab-raises-price-target-to-228

JP Morgan analyst Jeffrey Zekauskas maintains Ecolab (NYSE:ECL) with a Neutral and raises the price target from $225 to $228.

 rbc-capital-reiterates-outperform-on-ecolab-maintains-260-price-target

RBC Capital analyst Ashish Sabadra reiterates Ecolab (NYSE:ECL) with a Outperform and maintains $260 price target.

 baird-maintains-neutral-on-ecolab-raises-price-target-to-267

Baird analyst Andrew Wittmann maintains Ecolab (NYSE:ECL) with a Neutral and raises the price target from $243 to $267.

 citigroup-upgrades-ecolab-to-buy-lowers-price-target-to-265

Citigroup analyst Patrick Cunningham upgrades Ecolab (NYSE:ECL) from Neutral to Buy and lowers the price target from $267 to...

 b-of-a-securities-upgrades-ecolab-to-buy-raises-price-target-to-272

B of A Securities analyst Steve Byrne upgrades Ecolab (NYSE:ECL) from Neutral to Buy and raises the price target from $251 t...

 tech-stocks-drop-ahead-of-key-earnings-nvidia-falls-crowdstrike-hits-8-month-low-whats-driving-markets-tuesday

Investor sentiment took a hit on Tuesday as caution prevailed ahead of significant market events, including key tech earnings r...

 why-water-purification-services-provider-ecolabs-shares-are-trading-lower-today

Ecolab reported Q2 FY24 sales growth of 3.45% to $3.985 billion, missing the $4.028 billion estimate. Global Institutional &...

 ecolab-q2-2024-adj-eps-168-beats-167-estimate-sales-3985b-miss-4028b-estimate

Ecolab (NYSE:ECL) reported quarterly earnings of $1.68 per share which beat the analyst consensus estimate of $1.67 by 0.6 perc...

 citigroup-maintains-neutral-on-ecolab-raises-price-target-to-267

Citigroup analyst Patrick Cunningham maintains Ecolab (NYSE:ECL) with a Neutral and raises the price target from $257 to $267.

 rbc-capital-reiterates-outperform-on-ecolab-maintains-260-price-target

RBC Capital analyst Ashish Sabadra reiterates Ecolab (NYSE:ECL) with a Outperform and maintains $260 price target.

 ubs-maintains-buy-on-ecolab-raises-price-target-to-282

UBS analyst Joshua Spector maintains Ecolab (NYSE:ECL) with a Buy and raises the price target from $270 to $282.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION